We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure [email protected]
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter presents suggested options for the elimination of multiple pregnancies including selective fetal reduction, single blastocyst transfer and elective single-embryo transfer (eSET). Selective fetal reduction carries a risk of miscarriage and poses serious ethical and legal questions. Three trials comparing eSET with elective double embryo transfer (DET) were identified. All involved women who had undergone embryo transfer in a fresh in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) cycle. It is clear that in a selected population the cumulative outcome of eSET is comparable with that of DET while virtually eliminating multiple pregnancies. The outcome of an eSET policy can be substantially enhanced in conjunction with an efficient and reliable embryo cryopreservation programme. Twin pregnancies resulting from IVF treatment are associated with higher maternal and perinatal morbidity. More data from pragmatic trials are to demonstrate whether a policy of eSET is effective, acceptable and financially viable in other clinical settings.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.